Zingiberene
1. Identity: Chemical, Botanical, and Physical Characterization
Zingiberene is a monocyclic sesquiterpene that is the main flavor component of ginger, which is obtained from the root of the Chinese plant Zingiber officinale. Its systematic IUPAC name is 2-methyl-5-(6-methylhept-5-en-2-yl)cyclohexa-1,3-diene, and its molecular formula is C15H24. In terms of structural features, the compound features a cyclohexadiene ring with an isopropenyl side chain and a geranyl-like substituent.
Zingiberene can contribute up to 30% of the essential oils in ginger rhizomes. One detailed phytochemical study of Zingiber officinale rhizomes cultivated on ecological plantations in Shikoku Island, Japan, found that ninety-five percent of terpene composition was elucidated, with zingiberene as the most abundant sesquiterpene at 37.9%. The compound is the compound that gives ginger its distinct flavoring.
Zingiberene occurs in two principal stereoisomeric forms: α-zingiberene and 7-epi-zingiberene. Zingiberene and its stereoisomer 7-epi-zingiberene occur in the glandular trichomes of wild tomato plants (Solanum habrochaites), where they serve as key components of the plant's chemical defense against herbivores such as whiteflies (Bemisia tabaci).
1.1 Natural Sources Beyond Ginger
Although ginger is its primary and most concentrated natural source, zingiberene is found across several plant families. Zingiberene, in addition to being the most abundant molecule in ginger oil, is present in a wide range of plant species, including tomato, basil, turmeric, cardamom, and sorghum. In the hop plant (Humulus lupulus), zingiberene constitutes a significant portion of the essential oil, ranging from 5% to over 8% in various wild and cultivated varieties, and imparts characteristic aromatic notes to hop-derived products like beer.
Additionally, α-zingiberene is the major constituent of the essential oil from the leaves of Casearia sylvestris, a plant widely used in traditional medicine for the treatment of inflammatory diseases, tumours, and bacterial infections. A published GC-MS analysis of turmeric (Curcuma longa) leaf essential oil found that the presence of (−)-zingiberene at 17.84% made it one of the major phytocompounds detected.
1.2 Biosynthesis
Zingiberene is produced through the isoprenoid biosynthetic pathway. Zingiberene is formed in the isoprenoid pathway from farnesyl pyrophosphate (FPP). FPP undergoes a rearrangement to give nerolidyl diphosphate. After the removal of pyrophosphate, the ring closes, leaving a carbocation on the tertiary carbon attached to the ring. A 1,3-hydride shift then takes place to give a more stable allylic carbocation. In ginger (Zingiber officinale), FPP serves as the substrate for dedicated sesquiterpene synthases that catalyze the formation of α-zingiberene as the dominant product.
1.3 Common Forms and Preparations
Zingiberene as an isolated compound is not a common commercial dietary supplement; rather, it is encountered primarily as a constituent of ginger essential oil. The color of Z. officinale essential oil varies from pale yellow to light amber, and the extraction yield ranges from 1.5% to 3%. Preparations include steam-distilled or hydrodistilled essential oils, standardized ginger rhizome extracts (which may be in powdered, encapsulated, or liquid extract form), as well as fresh and dried rhizome preparations. Within the essential oil fraction, the most abundant compounds are α-zingiberene, responsible for the distinctive flavor and aroma, geranial, ar-curcumene, β-bisabolene, β-sesquiphellandrene, and neral.
The highest concentrations of volatiles in ginger are determined for α-zingiberene, β-sesquiphellandrene, (E,E)-α-farnesene, geranial, and ar-curcumene. The volatiles composition of ginger cultivated on Shikoku Island is specific and strongly differs from plants cultivated in China, Nigeria, or Australia. This geographic variation underscores that the zingiberene content of any ginger preparation depends heavily on cultivar, origin, and processing method.
2. Traditional and Historical Use
The historical use of zingiberene as an isolated molecule is non-existent in traditional medicine; rather, it is one of the principal active constituents responsible for the biological and organoleptic properties attributed over millennia to preparations of ginger rhizome. Its traditional history is therefore inseparable from the documented ethnobotanical record of Zingiber officinale and related species.
2.1 Traditional Chinese Medicine
Both Traditional Chinese Medicine (TCM) and Ayurveda have used ginger for over 3,000 years — not as a marginal folk remedy, but as a foundational therapeutic agent prescribed for dozens of conditions. Chinese records dating from the fourth century BC indicate that ginger was used to treat numerous conditions including stomachache, diarrhea, nausea, cholera, hemorrhage, rheumatism, and toothaches. Not only in Traditional Chinese Medicine, but also in modern China, ginger is used in about half of all herbal prescriptions, because of its ability to act as messenger, servant, and guide herb that brings other herbal medicines to the site where they are needed.
In Traditional Chinese Medicine, ginger is known as Sheng Jiang and is valued for its ability to dispel cold and dampness from the body. In TCM, ginger (sheng jiang for fresh, gan jiang for dried) is classified as a warm, pungent herb that expels cold, warms the middle burner (digestive system), and transforms phlegm. Zhang Zhongjing clearly proposed using ginger as medicine in Shang Han Za Bing Lun (Treatise on Febrile and Miscellaneous Diseases), such as Guizhi Shengjiang Zhishi Decoction and Shengjiang Xiexin Decoction.
2.2 Ayurveda
In Ayurveda, ginger is revered for its warming properties and is considered a powerful digestive aid. It is often used to balance the doshas, particularly Vata and Kapha, and is recommended for alleviating nausea, indigestion, and respiratory issues. The classical Ayurvedic text Charaka Samhita (written approximately 300 BCE) refers to ginger as "vishwabhesaj" — the universal medicine — reflecting its extraordinarily broad range of therapeutic applications. Ayurvedic practitioners commonly use ginger in various forms, including fresh, dried, or as a powder.
2.3 Other Ethnobotanical Traditions
Plants of the genus Zingiber (Family Zingiberaceae) are widely used throughout the world as food and medicinal plants. They represent very popular herbal remedies in various traditional healing systems; in particular, the rhizome of Zingiber spp. plants has a long history of ethnobotanical uses because of a plethora of curative properties. The rhizomes have been shown to be effective in the treatment of several medical conditions including stomach problems, nausea, vomiting, epilepsy, sore throat, cough, common cold, bruises, wounds, liver complaints, rheumatism, muscular pains, atherosclerosis, migraine headaches, high cholesterol, ulcers, and stomach discomfort.
The plant Casearia sylvestris, which contains α-zingiberene as its major essential oil constituent, has its own distinct ethnobotanical tradition. Popularly known as "guaçatonga," it is utilized in traditional medicine to treat several pathologic processes such as inflammation, skin lesions, and microbial infections. The leaves and bark are considered a purgative tonic and anti-rheumatic. The species also showed anti-inflammatory, antimicrobial, antiplasmodial, and anti-ulcer properties in in vitro and pre-clinical studies.
3. Key Constituents of the Ginger Essential Oil Matrix and Zingiberene's Role
Zingiberene does not act in isolation in any natural plant preparation. It is part of a complex phytochemical matrix. Antimicrobial activity of rhizome essential oil has been extensively confirmed in vitro and attributed to its chemical components, mainly consisting of monoterpene and sesquiterpene hydrocarbons such as α-zingiberene, ar-curcumene, β-bisabolene, and β-sesquiphellandrene. In addition, gingerols have been identified as the major active components in the fresh rhizome, whereas shogaols, dehydrated gingerol derivatives, are the predominant pungent constituents in dried rhizome.
Different studies have documented biological properties of the essential oil such as antimicrobial, antioxidant, cytotoxic, insecticidal, and anti-inflammatory effects, as well as food preservative characteristics. These properties have been attributed to the chemical components of Z. officinale essential oil, mainly consisting of monoterpene and sesquiterpene hydrocarbons.
4. Mechanisms of Action
4.1 Anti-Inflammatory Mechanisms
Research into the anti-inflammatory mechanisms of zingiberene, studied principally as an isolated compound from Casearia sylvestris or ginger essential oil fractions, reveals effects on several molecular targets. A murine subcutaneous implant study (Ferreira et al., 2022) demonstrated that treatment with the sesquiterpene resulted in a reduction in macrophage activation, as well as in mean blood vessels and in the activity of metalloproteinases 2 and 9. Furthermore, it resulted in an increase in collagen deposition near the implants.
For the broader ginger essential oil, of which zingiberene is the principal sesquiterpene, the antimicrobial activity of ginger oil can be attributed to its constituent monoterpenes and sesquiterpenes, as they are capable of altering the permeability and fluidity of the plasma membrane of microorganisms.
4.2 Anticancer Mechanisms
Studies on zingiberene's direct anticancer action have identified several intracellular pathways. In a 2019 preclinical study of colon cancer, the anticancer activity of zingiberene against HT-29 colon cancer cells was found to be due to induction of autophagy. The zingiberene-triggered autophagy was also linked with an increase in the expression of LC3-II and a decrease in p62 expression. It was found that zingiberene could inhibit the mTOR/PI3K/AKT signalling pathway in the colon cancer cells, and zingiberene also suppressed the weight and volume of the xenografted tumors concentration-dependently.
In a separate study of α-zingiberene's anti-proliferative effects on cancer cells, the mechanism by which α-zingiberene induces cell death in cancer cells is mainly through the apoptotic process. The compound causes the release of mitochondrial cytochrome c into the cytoplasm, which then activates caspase-3, an apoptotic effector.
A 2016 study examining the cytotoxicity of the essential oil of Zingiber officinale and its isolated α-zingiberene component found that the anti-proliferative effect of α-zingiberene is a result of apoptotic effects, and α-zingiberene is worth further study to develop it as a cancer chemotherapeutic.
4.3 Antioxidant Mechanisms
Zingiberene has demonstrated antioxidant capacity in cell culture models. A study by Togar et al. (2015) examining zingiberene in neuronal cell cultures found that survival and total antioxidant capacity (TAC) levels of the cells decreased, while total oxidative stress (TOS), 8-OH-dG levels, and the mean values of the total scores of cells showing DNA damage increased in H₂O₂ alone-treated cultures. But pretreatment with zingiberene suppressed the cytotoxicity, genotoxicity, and oxidative stress that were increased by H₂O₂.
4.4 Ecological / Plant-Defense Mechanism
Zingiberene, a sesquiterpene hydrocarbon, plays a key role in plant defense mechanisms within natural ecosystems, particularly through volatile emissions that deter herbivores and potentially mediate interspecies interactions. The widespread presence of this molecule in these plants is probably associated with its ability to defend them against parasitic insects; it is probable that this molecule fulfills various roles including that of inducing an interruption in the spawning of these insects, also dissuading them from feeding on the plant.
In the wild tomato, 7-epi-zingiberene seems to confer a particularly broad range of resistance against various pests, including pinworms (Tuta absoluta), whiteflies (Bemisia tabaci), spider mites (Tetranychus evansi), and Colorado potato beetle (Leptinotarsa decemlineata).
5. Scientific Evidence by Area of Use
Important caveat on evidence level: As of the available literature, no randomized controlled clinical trials have been conducted in human subjects using isolated zingiberene as the test substance. All evidence reviewed below is from in vitro (cell culture), in vivo (animal model), or in silico experiments. Any clinical relevance remains to be established through human trials. Studies conducted on whole ginger preparations, ginger extracts, or ginger essential oil — where the bioactive contribution of zingiberene relative to other co-occurring compounds is not individually delineated — are noted as such.
5.1 Anticancer Activity
Colon Cancer
A 2019 study published in the Journal of BUON (Chen et al.) investigated zingiberene's effects on HT-29 human colon cancer cells in vitro and in a xenograft mouse model. It was found that zingiberene could inhibit the mTOR/PI3K/AKT signalling pathway in the colon cancer cells, and zingiberene also suppressed the weight and volume of the xenografted tumors concentration-dependently. These results indicate that zingiberene may inhibit the growth of colon cancer in vitro and in vivo and may be used for the development of systemic therapy against colon cancer. This is preclinical evidence only; no human trial data exist for this indication.
Breast Cancer
A 2022 study published in the Journal of Biochemical and Molecular Toxicology (Seshadri et al.) assessed zingiberene's chemopreventive potential against mammary tumorigenesis. The anticancer actions of zingiberene were assessed against the 7,12-dimethylbenz(a)anthracene (DMBA)-stimulated mammary carcinogenesis in rats and MDA-MB-231 cells. Breast cancer was induced in female Sprague-Dawley rats through 25 mg/kg of DMBA in 0.5 ml of corn oil, and then treated with 20 and 40 mg/kg of zingiberene, respectively. Zingiberene substantially modulated the DMBA-stimulated physiological and hematological changes and decreased the transaminases and lipid peroxidation in the DMBA-stimulated animals. Zingiberene also elevated the antioxidant level and suppressed the inflammatory markers. Histological study revealed the protective effects of zingiberene. The viability of MDA-MB-231 cells was noticeably diminished by zingiberene, thus inducing apoptotic cell death. This study is animal- and cell-based; no human data exist.
5.2 Anti-Inflammatory Activity
The most specific published study on zingiberene's isolated anti-inflammatory and anti-angiogenic properties is from Ferreira et al. (2022, Natural Product Research). The effects of daily administration of α-zingiberene (0.01, 0.1 and 1 μg diluted in 10 μl of 0.5% DMSO) were evaluated on the inflammatory, angiogenic, and fibrogenic components, induced by subcutaneous sponge implants in an animal model. Treatment with the sesquiterpene resulted in a reduction in macrophage activation, as well as in mean blood vessels and in the activity of metalloproteinases 2 and 9. Furthermore, it resulted in an increase in collagen deposition near the implants. These results show the therapeutic potential of α-zingiberene in the treatment of pathologies in which processes such as inflammation and angiogenesis are exacerbated, or even for the treatment of chronic wounds. All these findings are limited to an animal model; no clinical translation has been reported.
5.3 Antimicrobial Activity
Antimicrobial activity of rhizome essential oil has been extensively confirmed in vitro and attributed to its chemical components, mainly consisting of monoterpene and sesquiterpene hydrocarbons such as α-zingiberene, ar-curcumene, β-bisabolene, and β-sesquiphellandrene. A scoping review of 28 studies on Zingiberaceae antimicrobials confirmed that out of the included 28 articles, 18 studies involved only in vitro experiments, 7 discussed only in silico analyses, and 3 conducted both in vitro and in silico analyses. No clinical trials testing isolated zingiberene for antimicrobial indications in humans have been identified.
For the broader ginger extract, one in vitro study found that the antifungal activity of ginger extract is much greater than fluconazole and nystatin against C. albicans. The contribution of zingiberene specifically to this activity, versus other co-occurring compounds such as gingerols, is not individually established by this or similar studies.
5.4 Antioxidant and Cytoprotective Activity (Neuroprotection)
Togar et al. (2015, Toxicology and Industrial Health) found in neuronal cell cultures that zingiberene (ZGB) pretreatment at 6.25–100 µg/ml exerted cytoprotective effects in hydrogen peroxide-stressed cells. Cytoprotective activities of ZGB on 0.5 mM H₂O₂-induced cell injury were investigated by MTT, LDH, TAC, TOS, and comet assays and 8-OH-dG analysis. For determining cytoprotectivity, the cells were seeded into a 48-well plate, then exposed to medium in the presence of different concentrations of ZGB for 0.5 h before exposure to 0.5 mM H₂O₂ for 6 h. These are in vitro neuroprotective findings with no parallel human data.
5.5 Plant Defense and Ecotoxicological Activity (Insecticidal)
Zingiberene and its stereoisomer 7-epi-zingiberene occur in the glandular trichomes of wild tomato plants (Solanum habrochaites), where they serve as key components of the plant's chemical defense against herbivores such as whiteflies (Bemisia tabaci). These sesquiterpenes are produced in high concentrations in certain accessions, contributing to the plant's resistance to insect pests. This activity is of agricultural rather than clinical pharmacological relevance.
6. Body Systems and Health Areas Associated with Zingiberene
- Gastrointestinal system: Since antiquity, ginger has been used for a wide array of unrelated ailments such as arthritis, rheumatism, sprains, muscular aches, pains, sore throats, cramps, constipation, indigestion, vomiting, hypertension, dementia, fever, infectious diseases, and helminthiasis — conditions in which the essential oil fraction, predominantly zingiberene, was a contributing constituent.
- Oncology (preclinical): Evidence from cell line and animal studies points to anticancer activity against colon and breast cancer models, via autophagy induction, PI3K/AKT/mTOR suppression, and apoptosis.
- Inflammatory and angiogenic processes: Animal model data suggest reduction of macrophage activation, metalloproteinase activity, and pathological angiogenesis.
- Antimicrobial: As a major constituent of ginger essential oil, zingiberene participates in the documented in vitro antibacterial and antifungal activity of the oil through membrane-disrupting mechanisms.
- Neurological (cytoprotection, preclinical): In vitro protection of neuronal cells against oxidative stress has been reported.
- Wound healing: Animal and cell culture models suggest pro-collagenic and wound-healing supportive properties linked to α-zingiberene.
7. Dosage Forms and Reported Dosages
No standardized clinical dosage for isolated zingiberene has been established, as it has not progressed to human clinical trials as an isolated agent. The following dosages are as reported in specific preclinical studies:
- Daily administration of α-zingiberene at 0.01, 0.1, and 1 μg diluted in 10 μl of 0.5% DMSO in a murine subcutaneous sponge implant model.
- Treatment doses of 20 and 40 mg/kg of zingiberene in female Sprague-Dawley rats in a DMBA-induced mammary carcinogenesis study.
- In neuronal cytoprotection studies, ZGB was applied into cultures at concentrations of 6.25, 12.5, 25, 50, and 100 µg/ml for 24 h.
- In cytotoxicity studies on rat brain cell cultures, ZBN showed anti-proliferative activity suppressing the proliferation of N2a-NB cells at concentrations over 50 mg L⁻¹ and neuron cells at concentrations over 150 mg L⁻¹.
For comparison, as a component of ginger essential oil, the oil itself is found in the rhizome at an extraction yield of approximately 1.5% to 3%, with zingiberene forming up to 30–38% of that oil depending on geographic origin and processing.
8. Safety Considerations
8.1 Cytotoxicity at Higher Concentrations
In vitro cytotoxicity studies reveal that zingiberene is not uniformly safe at all concentrations. ZBN showed anti-proliferative activity suppressing the proliferation of N2a-NB cells at concentrations over 50 mg L⁻¹ and neuron cells at concentrations over 150 mg L⁻¹. In addition, ZBN treatments at higher doses (≤50 mg L⁻¹) led to increases of TOS levels in N2a-NB cell cultures — indicating a pro-oxidant shift at elevated concentrations in cancer neuroblastoma cell lines.
8.2 Genotoxicity Assessment
A key in vitro safety study (2015, Cytotechnology, PMC4628918) evaluated zingiberene's genotoxic potential via comet (single-cell gel electrophoresis) assay in rat neuron and neuroblastoma cell lines. Comet assay was performed on healthy neuron and N2a-NB cell lines to measure the genotoxicity of ZBN. The mean values of the total scores of cells showing DNA damage were not found to be significantly different from the control values in both cells — suggesting absence of significant genotoxic effect at the concentrations tested. However, this is limited to one in vitro model and does not constitute formal genotoxicity clearance.
8.3 Toxicity Data Scarcity
Data on the toxicity of these essential oils [in which zingiberene is a major component] are scarce in the literature. No formal oral toxicity studies specifically for isolated zingiberene in mammalian models equivalent to ICH or OECD guidelines have been identified in the peer-reviewed literature.
8.4 Potential Interactions and Contextual Cautions
Because zingiberene is encountered in nature predominantly within ginger essential oil and ginger extracts — and not as an isolated commercial supplement — any interactions cited in the broader ginger literature are relevant context. Accumulated investigations have demonstrated that ginger possesses multiple biological activities, including antioxidant, anti-inflammatory, antimicrobial, anticancer, neuroprotective, cardiovascular protective, respiratory protective, antiobesity, antidiabetic, antinausea, and antiemetic activities — but the specific pharmacokinetic interactions of zingiberene as an isolated molecule with medications or other supplements have not been characterized in human studies.
8.5 Evidence Gaps and Regulatory Status
Zingiberene is not currently listed as an approved drug ingredient by regulatory bodies. It exists in the food supply as a naturally occurring component of ginger, which is generally recognized as safe (GRAS) as a food ingredient in many jurisdictions. The compound has not undergone formal clinical evaluation as an isolated bioactive. Zingiberene has not been thoroughly investigated as a standalone therapeutic agent, and its dose-response profile, pharmacokinetics, bioavailability following oral ingestion, and long-term safety in humans remain uncharacterized.
9. Summary of Evidence Strength
- Anticancer (colon, breast): Preliminary; animal and cell culture models only. Mechanistic data are internally consistent but clinical significance is unknown. No human trials.
- Anti-inflammatory / Anti-angiogenic: Preliminary; animal model evidence. No human trials.
- Antimicrobial: Mostly in vitro; zingiberene's individual contribution within whole-oil preparations not fully isolated. No human trials.
- Antioxidant / Neuroprotective: In vitro evidence only. No human trials.
- Ecological insecticidal: Well-established in plant biology literature; not directly clinically relevant.
- Overall: All clinical benefit claims for zingiberene as an isolated compound remain speculative from a clinical perspective. Evidence is entirely preclinical, with no published phase I, II, or III human studies as of the available literature.
References
Go back